These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 3291233)

  • 41. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 42. Low dose cyclosporine strategy for cadaver kidney transplantation.
    Barry JM; Serra JR; Hefty TR; Norman DJ; Bennett WM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):125-7. PubMed ID: 3515678
    [No Abstract]   [Full Text] [Related]  

  • 43. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 44. The efficacy of low doses of cyclosporine A plus azathioprine.
    Andreu J; Ricart MJ; Oppenheimer F; Vilardell J; Sans A
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):28-9. PubMed ID: 3051583
    [No Abstract]   [Full Text] [Related]  

  • 45. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of conversion from conventional immunosuppressive therapy to cyclosporin A in complications following kidney transplantation].
    Scholz D; Blank W; Bärwolf C; Ditscherlein G; Christenfeld R; Hüller H
    Z Urol Nephrol; 1990 Feb; 83(2):69-76. PubMed ID: 2368516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of triple therapy on graft outcome in renal transplantation.
    Cağlar S; Taşdemir I; Turgan C; Yasavul U; Bakkaloğlu M; Erkan I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):140-2. PubMed ID: 3291228
    [No Abstract]   [Full Text] [Related]  

  • 49. Minimal low dosage of cyclosporine therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels.
    Uchida K; Yamada N; Orihara A; Tominaga Y; Tanaka Y; Hayashi S; Kondo T; Morozumi K; Satake M; Taira N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):394-401. PubMed ID: 3284083
    [No Abstract]   [Full Text] [Related]  

  • 50. Conversion of long-term renal allograft recipients from prednisolone/azathioprine to cyclosporine monotherapy.
    Birkeland SA; Foged N; Kold AA; Svendsen V; Rohr N; Elbirk A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):171-5. PubMed ID: 3291237
    [No Abstract]   [Full Text] [Related]  

  • 51. Elective cyclosporine conversion from triple therapy.
    Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
    [No Abstract]   [Full Text] [Related]  

  • 52. [Immunosuppressive measures in renal transplantation].
    Ianhez LE
    AMB Rev Assoc Med Bras; 1987; 33(9-10):199-200. PubMed ID: 3333295
    [No Abstract]   [Full Text] [Related]  

  • 53. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts.
    Collier DS; Calne RY; De Curtins M; Thiru S; White DJ; Jamieson NV; Thick M; Barroso E
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1279-80. PubMed ID: 3274318
    [No Abstract]   [Full Text] [Related]  

  • 54. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1987 Oct; 19(5):3589-91. PubMed ID: 3313864
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation.
    Belitsky P; MacDonald A; Cohen A; VGivner M; Sketris I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):78-81. PubMed ID: 3291314
    [No Abstract]   [Full Text] [Related]  

  • 57. Low-dose triple immunosuppression in pediatric cadaveric renal transplantation.
    Francis DM; Walker RG; d'Apice AJ
    Transplant Proc; 1987 Oct; 19(5):3677-8. PubMed ID: 3313888
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical summation. An algorithm for the management of patients with cyclosporine-induced renal dysfunction.
    Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):303-8. PubMed ID: 3895669
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of cyclosporine A in combination with low-dose corticosteroids and azathioprine in liver transplantation.
    Gugenheim J; Samuel D; Saliba F; Castaing D; Bismuth H
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):366-8. PubMed ID: 3291269
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.